BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31108174)

  • 1. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.
    Eddings CR; Arbez N; Akimov S; Geva M; Hayden MR; Ross CA
    Neurobiol Dis; 2019 Sep; 129():118-129. PubMed ID: 31108174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
    Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model.
    Lenoir S; Lahaye RA; Vitet H; Scaramuzzino C; Virlogeux A; Capellano L; Genoux A; Gershoni-Emek N; Geva M; Hayden MR; Saudou F
    Neurobiol Dis; 2022 Oct; 173():105857. PubMed ID: 36075537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.
    Kusko R; Dreymann J; Ross J; Cha Y; Escalante-Chong R; Garcia-Miralles M; Tan LJ; Burczynski ME; Zeskind B; Laifenfeld D; Pouladi M; Geva M; Grossman I; Hayden MR
    Mol Neurodegener; 2018 May; 13(1):25. PubMed ID: 29783994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor.
    Shenkman M; Geva M; Gershoni-Emek N; Hayden MR; Lederkremer GZ
    J Neurochem; 2021 Jul; 158(2):467-481. PubMed ID: 33871049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models.
    Naia L; Ly P; Mota SI; Lopes C; Maranga C; Coelho P; Gershoni-Emek N; Ankarcrona M; Geva M; Hayden MR; Rego AC
    Neurotherapeutics; 2021 Apr; 18(2):1017-1038. PubMed ID: 33797036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine Protects Neurons from Mutant Huntingtin Toxicity.
    Arbez N; Roby E; Akimov S; Eddings C; Ren M; Wang X; Ross CA
    J Huntingtons Dis; 2019; 8(2):129-143. PubMed ID: 30856117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.
    Squitieri F; de Yebenes JG
    Drug Des Devel Ther; 2015; 9():5827-33. PubMed ID: 26604684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effects of σ
    Jin J; Arbez N; Sahn JJ; Lu Y; Linkens KT; Hodges TR; Tang A; Wiseman R; Martin SF; Ross CA
    ACS Chem Neurosci; 2022 Oct; 13(19):2852-2862. PubMed ID: 36108101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins.
    Ruiz C; Casarejos MJ; Rubio I; Gines S; Puigdellivol M; Alberch J; Mena MA; de Yebenes JG
    Brain Res; 2012 Jun; 1459():100-12. PubMed ID: 22560595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease.
    Francardo V; Geva M; Bez F; Denis Q; Steiner L; Hayden MR; Cenci MA
    Neurotherapeutics; 2019 Apr; 16(2):465-479. PubMed ID: 30756361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pridopidine in the treatment of Huntington's disease.
    Jabłońska M; Grzelakowska K; Wiśniewski B; Mazur E; Leis K; Gałązka P
    Rev Neurosci; 2020 May; 31(4):441-451. PubMed ID: 32083454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Ryskamp D; Wu L; Wu J; Kim D; Rammes G; Geva M; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2019 Apr; 124():489-504. PubMed ID: 30594810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model.
    Squitieri F; Di Pardo A; Favellato M; Amico E; Maglione V; Frati L
    J Cell Mol Med; 2015 Nov; 19(11):2540-8. PubMed ID: 26094900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons.
    Ruiz-Calvo A; Bajo-Grañeras R; Maroto IB; Zian D; Grabner GF; García-Taboada E; Resel E; Zechner R; Zimmermann R; Ortega-Gutiérrez S; Galve-Roperh I; Bellocchio L; Guzmán M
    Neuropharmacology; 2019 May; 150():134-144. PubMed ID: 30914306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pridopidine activates neuroprotective pathways impaired in Huntington Disease.
    Geva M; Kusko R; Soares H; Fowler KD; Birnberg T; Barash S; -Wagner AM; Fine T; Lysaght A; Weiner B; Cha Y; Kolitz S; Towfic F; Orbach A; Laufer R; Zeskind B; Grossman I; Hayden MR
    Hum Mol Genet; 2016 Sep; 25(18):3975-3987. PubMed ID: 27466197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.